Up | AC
Home Page
Food and
Drug Administration
Joint Meeting of the Antiviral Drugs Advisory Committee and the
Nonprescription Drugs Advisory Committee
October 29, 2008
FDA
Disclaimer
Portions of this
document have been determined to be exempt from disclosure under the Freedom of
Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Material
(pdf)
Hoffmann-La Roche Inc.
Disclaimer
The statements
contained in this document(s) are those of the product's sponsor, not FDA, and FDA
does not necessarily agree with the sponsor's statements. FDA has not made a
final determination about the safety or effectiveness of the product described
in this document.
Briefing Material (pdf)
GlaxoSmithKline
Disclaimer
The statements
contained in this document(s) are those of the product's sponsor, not FDA, and
FDA does not necessarily agree with the sponsor's statements. FDA has not made
a final determination about the safety or effectiveness of the product
described in this document.
Briefing Material (pdf